Resumen de acción ZBH
Zimmer Biomet Holdings, Inc. junto con sus filiales, opera como empresa de tecnología médica en todo el mundo.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Recompensas
Análisis de riesgos
Competidores de Zimmer Biomet Holdings, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$119.75 |
| 52 Week High | US$149.25 |
| 52 Week Low | US$102.00 |
| Beta | 1.02 |
| 1 Month Change | -6.35% |
| 3 Month Change | -1.59% |
| 1 Year Change | -13.44% |
| 3 Year Change | -32.95% |
| 5 Year Change | -2.81% |
| Change since IPO | 302.39% |
Noticias y actualizaciones recientes
Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20
Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Recent updates
Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
Mar 20Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Mar 02Zimmer Biomet Holdings' (NYSE:ZBH) Strong Earnings Are Of Good Quality
Feb 15What Does Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Share Price Indicate?
Feb 11Zimmer Biomet: Weight Loss Drug Concerns Are Overblown
Feb 05A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Jan 29Zimmer Biomet: Growth Acceleration Is Likely Driven By ROSA; Initiate With 'Buy'
Jan 20Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Not Flying Under The Radar
Jan 15The Returns At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Growing
Dec 31Zimmer Biomet Holdings: Visible Growth Drivers And Strong Execution
Dec 18Here's Why Zimmer Biomet Holdings (NYSE:ZBH) Can Manage Its Debt Responsibly
Dec 17Zimmer Biomet: Still Many Questions After A Solid Year So Far
Nov 26When Should You Buy Zimmer Biomet Holdings, Inc. (NYSE:ZBH)?
Nov 06Here's Why We Think Zimmer Biomet Holdings (NYSE:ZBH) Is Well Worth Watching
Oct 07Returns On Capital At Zimmer Biomet Holdings (NYSE:ZBH) Have Hit The Brakes
Sep 21Zimmer Biomet Holdings: Growth Strategies For 2023 Instill Confidence
Sep 14Calculating The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Sep 06Zimmer Biomet: Guidance Raise, Better Margins In 2024 Make It A Buy
Aug 11Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Aug 08Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Jul 10We Ran A Stock Scan For Earnings Growth And Zimmer Biomet Holdings (NYSE:ZBH) Passed With Ease
Jun 27Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Jun 13A Look At The Fair Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
May 30Zimmer Biomet: Expect Growth Momentum To Continue
May 26Is Zimmer Biomet Holdings (NYSE:ZBH) Using Too Much Debt?
May 04At US$129, Is It Time To Put Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On Your Watch List?
Apr 02Return Trends At Zimmer Biomet Holdings (NYSE:ZBH) Aren't Appealing
Mar 13A Look At The Intrinsic Value Of Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Feb 21Improving Ortho Performance At Zimmer Biomet Is Encouraging
Feb 09Zimmer Biomet Q4 2022 Earnings Preview
Feb 02We Think Zimmer Biomet Holdings (NYSE:ZBH) Can Stay On Top Of Its Debt
Jan 19Zimmer Biomet to acquire soft tissue healing company Embody
Jan 05Zimmer Biomet declares $0.24 dividend
Dec 15Should You Think About Buying Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Now?
Dec 03Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Could Be 26% Below Their Intrinsic Value Estimate
Nov 17Zimmer Biomet reports Q3 earnings beat; raises FY22 guidance range
Nov 02Slowing Rates Of Return At Zimmer Biomet Holdings (NYSE:ZBH) Leave Little Room For Excitement
Oct 24Is Zimmer Biomet Holdings (NYSE:ZBH) A Risky Investment?
Oct 10Zimmer's shoulder replacement system Identity gets FDA clearance
Sep 20Zimmer Biomet Is Likely Set For Even More Weakness (Technical Analysis)
Sep 14Zimmer Biomet Holdings (NYSE:ZBH) Is Due To Pay A Dividend Of $0.24
Sep 12Zimmer, Surgical Planning team up to sell mixed reality navigation system HipInsight
Sep 01Zimmer Biomet Holdings (NYSE:ZBH) Will Pay A Dividend Of $0.24
Aug 29Zimmer Biomet declares $0.24 dividend
Aug 26Zimmer Biomet: Slow Growing Market Leader
Aug 20Are Investors Undervaluing Zimmer Biomet Holdings, Inc. (NYSE:ZBH) By 43%?
Aug 04Rentabilidad de los accionistas
| ZBH | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | 0.4% | 1.6% | 1.0% |
| 1Y | -13.4% | -1.4% | 21.9% |
Rentabilidad vs. Industria: ZBH obtuvo unos resultados inferiores a los del sector US Medical Equipment , que el año pasado arrojó un rendimiento del -0.5%.
Rentabilidad vs. Mercado: ZBH obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| ZBH volatility | |
|---|---|
| ZBH Average Weekly Movement | 3.0% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: ZBH no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de ZBH (3%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1927 | 18,000 | Ivan Tornos | www.zimmerbiomet.com |
Zimmer Biomet Holdings, Inc. junto con sus filiales, opera como empresa de tecnología médica en todo el mundo. La empresa diseña, fabrica y comercializa productos ortopédicos reconstructivos, como productos para la rodilla y la cadera; productos S.E.T., incluidos productos de medicina deportiva, biológicos, para pie y tobillo, extremidades y traumatología; productos craneomaxilofaciales y torácicos que comprenden productos de reconstrucción facial y craneal, así como productos que fijan y estabilizan los huesos del tórax para facilitar la cicatrización o la reconstrucción tras una operación a corazón abierto, un traumatismo o para deformidades del tórax. También ofrece productos robóticos, quirúrgicos y de cemento óseo.
Resumen de fundamentos de Zimmer Biomet Holdings, Inc.
| Estadísticas fundamentales de ZBH | |
|---|---|
| Capitalización bursátil | US$24.60b |
| Beneficios(TTM) | US$1.02b |
| Ingresos (TTM) | US$7.39b |
24.0x
Ratio precio-beneficio (PE)3.3x
Ratio precio-ventas (PS)¿Está ZBH sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ZBH | |
|---|---|
| Ingresos | US$7.39b |
| Coste de los ingresos | US$2.08b |
| Beneficio bruto | US$5.31b |
| Otros gastos | US$4.29b |
| Beneficios | US$1.02b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 02, 2024
| Beneficios por acción (BPA) | 4.98 |
| Margen bruto | 71.82% |
| Margen de beneficio neto | 13.85% |
| Ratio deuda/patrimonio | 47.9% |
¿Cómo se ha desempeñado ZBH a largo plazo?
Ver rendimiento histórico y comparativa